ARTICLE | Distillery Therapeutics
Transplant
November 26, 2018 8:11 PM UTC
Mouse studies suggest APOA/phospholipid-based nanoparticles loaded with rapamycin or a TRAF6 inhibitor could help prevent heart transplant rejection. The nanoparticles consist of APOA and natural phos...